South Grafton, MA, United States of America

Cecilia M Bastos

This inventor holds 32 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Cystic Fibrosis Treatment. Top assignees: Proteostasis Therapeutics, Inc., Genzyme Corporation, Kineta, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 32 (Patent Applications = 12)

% Patents Active = 78.1

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 161(Granted Patents)

Location History:

South Grafton, MA (US) (2006 - 2023)
S. Grafton, MA (US) (2017 - 2024)

Company Filing History:

20 out of 24

Proteostasis Therapeutics, Inc.

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Proteasome Activity Enhancers

CFTR Modulation

Cystic Fibrosis

Glucosylceramide Synthase Inhibitors

Phosphate Transport Inhibitors

Compositions

Compounds

Methods

Activity Enhancement

Derivatives

Carboxylic Amides

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12319698 - Proteasome activity enhancing compounds (2025-06-03),

2. 11958873 - Proteasome activity enhancing compounds (2024-04-16),

3. 11560385 - Proteasome activity enhancing compounds (2023-01-24),

4. 11248010 - Compounds, compositions, and methods for modulating CFTR (2022-02-15),

5. 11242361 - Proteasome activity enhancing compounds (2022-02-08),

6. 11136313 - Compounds, compositions, and methods for modulating CFTR (2021-10-05),

7. 11098035 - Compounds, compositions, and methods for increasing CFTR activity (2021-08-24),

8. 11083709 - Compounds, compositions, and methods of increasing CFTR activity (2021-08-10),

9. 10899751 - Compounds, compositions, and methods for increasing CFTR activity (2021-01-26),

10. 10738040 - Compounds, compositions, and methods for increasing CFTR activity (2020-08-11),

11. 10738011 - Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis (2020-08-11),

12. 10662207 - Compounds, compositions, and methods for modulating CFTR (2020-05-26),

13. 10550106 - Compounds, compositions, and methods for modulating CFTR (2020-02-04),

14. 10548878 - Compounds, compositions, and methods of increasing CFTR activity (2020-02-04),

15. 10392378 - Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis (2019-08-27),

Title: Inventor Cecilia M Bastos - Revolutionizing Technology

Introduction: Cecilia M Bastos, a pioneering inventor hailing from South Grafton, MA (US), is a visionary woman who has made significant contributions to the world of technology through her innovative creations.

Latest Patents: Cecilia M Bastos holds several groundbreaking patents in the field of artificial intelligence and renewable energy technologies, showcasing her commitment to sustainable innovation.

Career Highlights: With a career spanning over two decades, Cecilia has worked tirelessly to develop cutting-edge solutions that have revolutionized various industries. Her passion for pushing the boundaries of technology is evident in the impact of her inventions.

Collaborations: Throughout her career, Cecilia has collaborated with leading research institutions, universities, and tech companies to bring her ideas to life. Her ability to work in diverse teams has led to the successful implementation of her inventions on a global scale.

Conclusion: Cecilia M Bastos stands as a beacon of innovation, inspiring future generations of inventors to dream big and create a better world through technology. Her relentless pursuit of excellence and dedication to making a positive impact continue to shape the landscape of innovation.